Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Aytu BioPharma Inc. (AYTU) had Receiveable Turnover of 3.71 for the most recently reported fiscal year, ending 2023-06-30.
| Income Statement Financials | |
$107.40M |
|
$-17.05M |
|
$40.77M |
|
$66.63M |
|
$124.46M |
|
$-17.07M |
|
$0.01M |
|
$-17.05M |
|
$-17.05M |
|
$-17.05M |
|
$-17.05M |
|
$-17.05M |
|
$-17.05M |
|
$-17.07M |
|
$-1.99M |
|
3.34M |
|
3.34M |
|
$-5.11 |
|
$-5.11 |
|
| Balance Sheet Financials | |
$72.83M |
|
$1.81M |
|
$63.63M |
|
$136.46M |
|
$69.02M |
|
$14.71M |
|
$28.09M |
|
$97.11M |
|
$39.36M |
|
$-19.61M |
|
$39.36M |
|
5.52M |
|
| Cash Flow Statement Financials | |
$-5.13M |
|
$-0.12M |
|
$8.87M |
|
$19.36M |
|
$22.98M |
|
$3.62M |
|
$6.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.06 |
|
-- |
|
-- |
|
0.27 |
|
0.42 |
|
62.04% |
|
-15.89% |
|
-15.89% |
|
-1.85% |
|
-15.88% |
|
-15.88% |
|
$-5.13M |
|
-- |
|
-- |
|
-- |
|
0.79 |
|
3.40 |
|
|
Receiveable Turnover |
3.71 |
98.34 |
|
-43.32% |
|
86.94% |
|
-12.49% |
|
-31.54% |
|
$7.13 |
|
$-1.54 |
|
$-1.54 |
|